There are 2934 resources available
Proffered Paper 1 - NSCLC, metastatic - Invited Discussant 1478O and 1479O
Presenter: Lizza Hendriks
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Slides
Webcast
Proffered Paper 1 - NSCLC, metastatic - Invited Discussant LBA79 and LBA80
Presenter: Naiyer Rizvi
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Slides
Webcast
1638 - Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Presenter: Fabrice Barlesi
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
4648 - Prognostic role of the EANO ESMO classification of leptomeningeal metastases
Presenter: Emilie Le Rhun
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
4361 - A Phase 0/2 Clinical Trial of a CDK4/6 Inhibitor in Aggressive Meningioma Patients
Presenter: Nader Sanai
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
1688 - Health-related quality of life (HRQoL) evaluation in the REGOMA trial: a randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients
Presenter: Mario Caccese
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
4884 - Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain
Presenter: Laura Chow
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
2693 - Integrated Genomic and DNA Methylation Analyses of Non-Small Cell Lung Cancer Patients with Brain Metastases
Presenter: Yanjun Xu
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
5130 - OCTOPUS - A Randomised, Multi-centre Phase II Umbrella Trial of Weekly Paclitaxel+/- Novel Agents in Platinum-Resistant Ovarian Cancer: vistusertib
Presenter: Susana Banerjee
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Yes
Presenter: Rebecca Dent
Session: Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)?
Resources:
Slides
Webcast